Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood creatine kinase amount,,RS:0004632,SD-Fhem1+/-,male,0 days,3,,CMO:0002242,blood creatine kinase activity level,,,,41,IU/l,0.5774,1.0,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104983,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood creatine kinase amount,,RS:0004632,SD-Fhem1+/-,female,0 days,3,,CMO:0002242,blood creatine kinase activity level,,,,34.5,IU/l,3.2332,5.6,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104984,control condition